216
Black Diamond Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
128
FY23:
134
FY24:
101
FY25:
132
(positive)
Change from FY21 to FY25
millions USD
FY21:
32.0
FY22:
28.5
FY23:
24.5
FY24:
21.5
FY25:
10.6
Total assets
Change from FY21 to FY25
millions USD
FY21:
248
FY22:
156
FY23:
159
FY24:
123
FY25:
143
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
23.6
FY22:
15.3
FY23:
19.6
FY24:
20.6
FY25:
15.7
(negative)
Change from FY21 to FY25
millions USD
FY21:
28.1
FY22:
25.3
FY23:
22.2
FY24:
18.8
FY25:
15.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
196
FY22:
116
FY23:
117
FY24:
83.3
FY25:
112
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
248
FY22:
156
FY23:
159
FY24:
123
FY25:
143
All amounts in millions USD